Su, Xiao <br/><br/>
Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance.  [electronic resource] 

 -  Nanomedicine (London, England)  2015 
 - 2033-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1748-6963 
<br/><br/><label>Standard No.: </label>10.2217/nnm.15.50  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Animals<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Cell Line, Tumor<br/>Ceramides--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Combinations<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Glucosyltransferases--genetics<br/>Humans<br/>Liposomes<br/>Mice<br/>Neoplasms--drug therapy<br/>Polyethylene Glycols--administration & dosage<br/>Up-Regulation--drug effects